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- antibodies alone confer limited protection against N. caninum infection 
 
- IFN- is vital in vaccination-induced protection against N. caninum in Il12b-/- mice 
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ABSTRACT 26 
We have recently demonstrated the effectiveness of an intranasal 27 
immunization approach against Neospora caninum infection in immunosufficient 28 
mice. Generated evidence indicated that antibodies could be mediating the 29 
observed protection. We similarly immunized IL-12/IL-23 p40 chain-deficient 30 
(Il12b-/-) mice, which have impaired cellular immunity, to further explore the host 31 
protective mechanism conferred by the used immunization strategy. The 32 
immunized mice presented lower parasitic burdens after intraperitoneal infection 33 
with N. caninum and also had elevated levels of parasite-specific antibodies. 34 
However, passive immunization with antibodies purified from immunized donors 35 
conferred only limited protection to infected Il12b-/- recipients. Despite their 36 
intrinsic IL-12 deficiency, the immunized Il12b-/- mice mounted a parasite-specific 37 
immune response that was mediated by interferon- (IFN-). Neutralization of 38 
IFN- in the immunized mice abrogated the observed protective effect of the 39 
immunization. These results show altogether that the used immunization strategy 40 
overcome the cellular immunity defect of Il12b-/- mice and conferred protection 41 
from N. caninum infection.  The observed protective effect was predominantly 42 
mediated by IFN- and to a lesser extent but non-negligibly by IgG antibodies. 43 
These results also highlight that in a host with compromised cellular immunity, 44 
the immune response against intracellular pathogens could be markedly boosted 45 
by immunization. 46 
  47 
1. Introduction 48 
Neospora caninum is an obligate intracellular apicomplexa protozoan that 49 
can infect a wide range of mammals of which cattle is the economically relevant 50 
host [1]. Cattle infection with N. caninum is associated with high economic losses 51 
due to an increased abortion rate observed in infected animals [2]. Although 52 
vaccination is estimated to be most effective strategy to control neosporosis, no 53 
commercial vaccine effective against this parasitic disease is currently available 54 
[3]. As N. caninum is an obligate intracellular protozoan, it could be expected that 55 
Th1-type cell-mediated immunity would be essential for parasite control. Indeed, 56 
previous studies have shown that mice defective in the IL-12/IFN- axis were 57 
lethally susceptible to this parasite [4-9]. Nevertheless, B-cell deficient mice also 58 
displayed marked susceptibility to N. caninum infection, suggesting that 59 
antibodies could also have a host protective role [10]. In that line, several studies 60 
reported that in vitro infection of host cells by N. caninum was impaired by 61 
antibodies specific for parasite antigens mediating attachment to and invasion of 62 
host cells [11-17].  63 
We have recently reported that intranasal (i.n.) immunization using a N. 64 
caninum antigen extract and CpG adjuvant conferred long lasting protection 65 
against neosporosis established via the gastrointestinal tract [18]. As both 66 
intestinal IgA and serum IgG raised by immunization displayed in vitro effector 67 
function by agglutinating parasites and decreasing host cell parasitic burden, we 68 
hypothesized that antibodies could be mediating the observed protection [18, 19].  69 
IL-12 is a heterodimeric cytokine formed by polypeptide chains p40 and p35, that 70 
in its immunologically active form is designated as IL-12 p70. IL-12 p40 chain 71 
may also associate with IL-23p19 to form IL-23 [20]. IL-12/IL-23 p40-deficient 72 
(Il12b-/-) mice have impaired cellular immunity [21] and are lethally susceptibility 73 
to N. caninum infection [9]. Taking into account these features, we used Il12b-/- 74 
mice as model to assess the role of systemic parasite-specific IgG antibodies, 75 
generated by immunization, in protection against neosporosis. Here infection was 76 
established by the intraperitoneal route, to overcome the effect of the intestinal 77 
barrier and of locally produced IgA. The obtained results showed that in the il12b-78 
/- background, the used mucosal immunization approach still induced a Th1-type 79 
immune response, which contributed to protection.  80 
  81 
 82 
2. Materials and methods 83 
 84 
2.1 Animals 85 
Female or Il12b-/- mice in the C57BL/6 background were purchased from Jackson 86 
Laboratories (Bar Harbor, Maine, USA) and bred under specific pathogen-free 87 
conditions at the animal facility of Instituto de Ciências Biomédicas Abel Salazar 88 
(ICBAS). Housing and nesting materials were provided as enrichment. 89 
Experiments were approved by the institutional board responsible for animal 90 
welfare at ICBAS (document 109/2015) and by the competent national authority 91 
(documents 0420/000/000/2010 and 0421/000/000/2016). 92 
 93 
2.2. Growth of parasites and preparation of tachyzoite lysates and cell-membrane 94 
extracts 95 
N. caninum tachyzoites (Nc1 isolate) were kept by serial passages in VERO cells 96 
cultures and isolated as previously described [8]. Parasite concentration in cell 97 
suspensions was determined in a hemocytometer. Whole parasite sonicates 98 
lysates (NcS) and N. caninum antigen extracts enriched in membranar proteins 99 
(NcMP) were prepared and analyzed accordingly to previously described 100 
methods [19].  101 
 102 
2.3. Immunizations and tissue sample collection 103 
Mice, 8-10 weeks-old, were randomly distributed into 2 groups. Animals were 104 
immunized i.n. twice with three-week interval under light isoflurane anesthesia 105 
with 20 µl of PBS containing 10 µg of CpG ODN 1826 (VacciGrade, Invivogen, 106 
San Diego, CA) (CpG group) or with PBS containing 30 µg of NcMP plus 10 µg 107 
of CpG ODN 1826 (NcMP/CpG group). Three weeks after the boost 108 
immunization, mice were either sacrificed by cervical dislocation upon isoflurane 109 
anesthesia for organ collection or i.p. challenged with 1 × 104 N. caninum 110 
tachyzoites, respectively. Infected mice were similarly sacrificed three and seven 111 
days after infection. Spleens and mesenteric lymph nodes (MLN) were collected 112 
for analysis of the elicited immune response. The brain and lungs were collected 113 
and stored at -20 ºC until DNA extraction. Serum was collected from all infected 114 
mice for detection of NcMP-specific antibodies. 115 
 116 
2.4. In vivo IFN- neutralization  117 
Neutralization of IFN- was performed 12 h before the i.p. parasitic challenge by 118 
i.v. administration of 500 µg of anti-IFN- mAb (clone R4-6A2) or rat IgG1 isotype 119 
control (clone HRPM), both from BioXcell (West Lebanon, NH, USA). Mice were 120 
sacrificed 7 days after infection. Brains were collected and stored frozen at -20 121 
ºC for DNA extraction.  122 
 123 
2.5. Antibody detection 124 
Serum titres of NcMP-specific IgG, IgG1 and IgG2c were quantified by ELISA as 125 
previously described [19], using respective alkaline phosphatase-coupled goat 126 
anti-mouse antibodies (all from Southern Biotechnology Associates, Birmingham, 127 
USA). 128 
 129 
2.6. Purification of serum IgG and passive immunization 130 
Serum samples collected from NcMP/CpG and CpG mouse groups three weeks 131 
after the boost immunization were pooled and IgG purified using a HiTrap Protein 132 
G HP purification column (GE healthcare), according to manufacturer’s 133 
instructions. Obtained IgG fractions were respectively designated IgG-NcMP and 134 
IgG-CpG. 135 
The recovered antibodies were dialyzed against sterile PBS and the IgG 136 
concentration was adjusted to 1.5 mg/ml before stored at -20 ºC. The NcMP-137 
specific antibody titres of the IgG-NcMP and IgG-CpG preparations were 1.559 × 138 
109 and below the detection limit, respectively, as determined by ELISA. Passive 139 
immunization was performed by intravenous (i.v.) injection of 200 µg IgG-CpG 140 
per mouse (IgG-CpG group) or 200 µg IgG-NcMP (IgG-NcMP group). Twelve 141 
hours following IgG transfer, mice were i.p. infected with 1 × 104 N. caninum 142 
tachyzoites. Mice were sacrificed seven days after infection and the brains were 143 
collected and stored at -20 ºC for DNA extraction. 144 
 145 
2.7. In vitro cell cultures and cytokine detection 146 
To assess cytokine production, spleens aseptically collected from mice sacrificed 147 
at specific time-points were homogenized and red blood cells were lysed. 148 
Recovered splenocytes were suspended in RPMI-1640 (Sigma), supplemented 149 
with 10% fetal calf serum (Biowest), HEPES (10 mM), penicillin (200 IU/ml) and 150 
streptomycin (200 µg/ml) (all from Sigma) and β-mercaptoethanol (0.1 μM) (Merk, 151 
Darmstadt, Germany) (RPMI), plated (5 × 105/well) in triplicate per animal in 152 
round-bottom 96-well plates (Nunc) and stimulated with NcS (60 µg/ml) for 3 days 153 
at 37 ºC and 5% CO2. Non-stimulated conditions were set to assess basal 154 
cytokine production. The concentration of IFN- and IL-4 in cell culture 155 
supernatants were respectively quantified with Mouse IFN- and IL-4 ELISA 156 
Ready-Set-Go!® (eBioscience, San Diego, CA) kits, according to manufacturer’s 157 
instructions.  158 
 159 
2.8. DNA extraction and real-time PCR analysis 160 
DNA was extracted from the brain of infected mice as previously described [22]. 161 
Briefly, brains were weighted and homogenized. Samples were incubated 162 
overnight at 55 ºC in a solution containing 1% SDS and 1 mg/ml Proteinase K 163 
(sigma). DNA was extracted by the phenol (Sigma)-Chlorophorm (Merk) method 164 
followed by ammonium acetate/ethanol precipitation. Parasite burden in the 165 
brains of infected mice was assessed by quantitative real-time PCR (qPCR) 166 
analysis of parasitic DNA performed as previously described [23]. In all runs, 167 
parasite burden was determined by interpolation of a standard curve performed 168 
with DNA isolated from N. caninum tachyzoites, ranging from 10 to 10×10-4 ng of 169 
parasitic DNA (2 to 2×105 parasites), included in each run. Data were analyzed 170 
in the Rotor gene 6000 so ware v1.7 (Corbett life science) and expressed as 171 
log10 parasites per g of tissue. 172 
 173 
2.9. Statistical analysis 174 
Statistical analyses were performed using GraphPad prism, Version 5.0 175 
(GraphPad Software, Inc., La Jolla, CA). In scatter dot graphs a horizontal bar 176 
indicates the mean for each group. Column graphs represented the mean values. 177 
Statistical analysis between groups was done using unpaired Student’s t-test or 178 
analysis of variance (ANOVA) as indicated in figure legends. 179 
  180 
3. Results 181 
3.1. Reduced parasitic burden in immunized Il12b-/- mice infected with N. caninum 182 
Mucosal immunization of Il12b-/- mice with NcMP plus CpG adjuvant raised 183 
the titers of NcMP-specific serum IgG, of both IgG1 and IgG2c isotypes. In sham-184 
immunized controls no serum parasite-specific IgG was detected (Fig. 1A). 185 
Moreover, higher levels of IFN- were detected in culture supernatants of NcS-186 
stimulated splenocytes and MLN cells obtained from the immunized mice 187 
comparatively to controls. IL-4 levels were found near the detection limit for all 188 
assessed groups (Fig. 1B). These results indicate that despite having a 189 
compromised IL-12/IFN- axis, Il12b-/- mice mounted a Th1-type response in 190 
response to the i.n. immunization Having confirmed the effectiveness of 191 
immunization, mice were infected i.p. with N. caninum and the parasitic burden 192 
was assessed in the lungs and brain at days 3 and 7 after the parasitic challenge, 193 
respectively. As shown in Fig. 2A, immunized mice clearly presented lower 194 
parasitic burdens than sham-immunized controls. In several immunized animals, 195 
no parasitic DNA was detected both in the lungs and brain. In the immunized 196 
mice the levels of NcMP-specific IgG were elevated after the parasitic challenge, 197 
with a preponderant IgG2c production (Fig. 2B). Splenocytes from 3-day infected 198 
immunized mice responded ex vivo to parasite antigen stimulation by producing 199 
IFN- whereas this was not observed in controls. Splenocytes from 7-day infected 200 
mice of the CpG and NcMP/CpG groups responded to in vitro NcS stimulation by 201 
producing IFN- to similar levels. The levels of IL-4 detected in culture 202 
supernatants were low in cultures of 3-day infected mice splenocytes. In the 203 
cultures of splenocytes from 7-day infected mice, IL-4 levels increased but were 204 
not different between groups (Fig. 2C). These results altogether show that the 205 
used intranasal immunization strategy induced parasite-specific IgG antibodies 206 
and the production of IFN- by Il12b-/- mice and conferred protection against 207 
infection with N. caninum established by the i.p. route. 208 
 209 
3.2. Passive immunization confers limited host protection against N. caninum 210 
challenge 211 
To determine whether the IgG antibodies raised by immunization could be 212 
mediating the protective effect observed in the infected mice, IgG-NcMP and IgG-213 
CpG were respectively transferred into naïve Il12b-/- recipients that were infected 214 
i.p. 12 h upon the passive immunization. As shown in Fig. 3, a reduction in 215 
parasitic burden was observed in mice that received IgG-NcMP in comparison 216 
with controls transferred with IgG-CpG. However, the protective effect was slight 217 
and less marked than the one induced by active immunization. This result 218 
indicates that IgG induced by immunization did not per se confer the protection 219 
observed in the i.n.-immunized mice.  220 
 221 
3.3. IFN- production in infected immunized Il12b-/- mice mediates protection 222 
As IgG antibodies only partially mediated the protective effect induced by 223 
the immunization, the contribution of IFN- to protection was assessed using a 224 
specific mAb to neutralize this cytokine. As shown in Fig. 4A, the protective effect 225 
induced by immunization was markedly impaired in mice receiving IFN--226 
neutralizing mAb. IFN- neutralization also raised the parasitic burden in controls 227 
sham-immunized with CpG. These results implicate IFN- in the protective effect 228 
induced by immunization in the Il12b-/- mice. IL-18 is a well-known IFN--inducing 229 
factor [24]. However, antibody-mediated neutralization of IL-18 did not affect the 230 
production of IFN- in in vitro NcS-stimulated mononuclear splenocytes obtained 231 
from the immunized Il12b-/- mice (Supplementary material 1). As shown in Figure 232 
4B, neutralization of IFN- 12 h prior to infection did not significantly affect the 233 
levels of parasite-specific IgG2c. However, the importance of IFN- in inducing 234 
the IgG2c response during immunization is evidenced by the absence of parasite-235 
specific antibodies of this isotype in immunized IFN- deficient mice 236 
(Supplementary material 2).   237 
4. Discussion 238 
Previous studies have demonstrated the essential role of the IL-12/IFN-  239 
axis in host resistance against N. caninum infection [4-9]. This could be expected 240 
taking into account that this protozoan is an obligate intracellular parasite. 241 
Nevertheless, we previously showed in vitro that parasite-specific antibodies 242 
raised by immunization agglutinated N. caninum tachyzoites and reduced 243 
parasitic burden in infected macrophages [18, 19]. Therefore, we hypothesized 244 
that in immunized mice antibodies could contribute to the protective effect. B cell-245 
deficient mice are highly susceptibility to infection caused by N. caninum [10], 246 
also indicating a possible role for antibody production in protection against this 247 
parasite. To further explore this hypothesis, we immunized and infected Il12b-/- 248 
mice, which have impaired cellular immunity but a normal B cell compartment 249 
[21]. The i.p. route was chosen to exclude a role of mucosal IgA in protection. 250 
Immunized Il12b-/- mice presented parasite-specific IgG levels similar to those 251 
previously detected in similarly immunized WT mice [18]. This indicates that 252 
absence of IL-12/IL-23 did not significantly impact IgG production induced by the 253 
i.n. immunization. IgG production independent of IL-12/IL-23 signaling, elicited by 254 
i.n. immunization, has been also reported by others using an alternative antigen 255 
and adjuvant [25]. In another study, Il12b-/- mice of the same background 256 
(C57BL/6) as used here, immunized subcutaneously with a parasite antigen plus 257 
CpG adjuvant produced IgG at the same level as wild-type mice [26]. However, 258 
the isotype profile was biased towards IgG1, contrasting our observation in the 259 
NcMP/CpG mice, where a preponderant production of IgG2c was still detected in 260 
response to immunization. This discrepancy may result from and highlight 261 
specific immune mechanisms elicited by mucosal immunization. 262 
The hypothesized protective role of IgG in N. caninum infected hosts was 263 
confirmed here in vivo in passively immunized animals. Passive immunization 264 
with antibodies has previously been shown to mediate protection in mice infected 265 
with the closely related protozoan Toxoplasma gondii, likely by inhibiting parasite 266 
penetration into host cells [27, 28]  or by promoting parasite intracellular killing by 267 
macrophages [29, 30]. However, the protective effect of antibody observed here 268 
was limited as it caused only a small reduction in the parasitic burden. As Il12b-/- 269 
mice have an impaired production of IFN- when infected with N. caninum [31], a 270 
protective role of antibodies in promoting intracellular killing may also depend on 271 
an intact capacity to produce this cytokine. Nonetheless, even in an 272 
immunosufficient recipient, transfer of immune serum raised in Il12b-/- mice failed 273 
to confer protection against Plasmodium berghei sporozoite infection [32]. The 274 
observed limited protection conferred by antibodies altogether with the lethal 275 
susceptibility of B cell-deficient mice to N. caninum [10] may also indicate that B 276 
cells participate in host protection against N. caninum by further mechanisms 277 
than antibody production such as providing co-stimulatory ligands for T cells [33] 278 
or by producing pro-inflammatory cytokines  [34]. 279 
Taking into consideration the IL-12/IL-23-deficient phenotype, it was 280 
surprising that IgG2c was the predominant isotype in the serum of the immunized 281 
Il12b-/- mice, due to the importance of IFN- in IgG2c production [35]. A possible 282 
explanation may reside in a direct effect of used CpG adjuvant in B cells, driving 283 
Toll-Like Receptor 9 (TLR9) dependent IgG2c class-switch [36]. CpG may also 284 
induce IFN- production by NK cells via TLR9. However, this effect was shown to 285 
also require concomitant IL-15 and IL-18 [37], that act in combination with IL-12 286 
[38], which would be prevented in the Il12b-/- background. The elevated levels of 287 
IgG2c antibodies induced by immunization were still detected in infected mice in 288 
which IFN- was neutralized by specific mAb. This shows that IgG2c-switched B 289 
cells, as a consequence of immunization, do not need IFN- produced in the 290 
course of acute infection to sustain the production of antibodies of this isotype. In 291 
accordance with the IgG isotype profile, production of IFN- was higher in cultures 292 
of parasite antigen-stimulated spleen and MLN cells obtained from immunized 293 
mice. The stimulatory effect of CpG in IFN- production is well-known [39-41] and, 294 
as we show here, it can also occur in the absence of IL-12. As CpG can also 295 
promote the production of IL-18 [42], this cytokine may be a possible candidate 296 
for the induction of IFN- production in immunized mice. Indeed, generation of 297 
IFN--mediated memory responses and host protection in the absence of 298 
endogenous IL-12 has already been described following infection with other 299 
protozoa [32, 43, 44] in a process dependent on IL-18 [43]. However, as 300 
neutralization of this cytokine did not affect in vitro parasite-antigen-driven IFN- 301 
production by splenocytes of immunized Il12b-/- mice, this hints that other 302 
cytokines may be more important in promoting the production of IFN- in 303 
response to immunization. IL-12 upregulates the expression of the IL-18 receptor 304 
on cells producing IFN- [45], and this may have limited the effect of IL-18 in the 305 
IL-12-deficient mice splenocyte cultures. A role for IL-18 in the in vivo 306 
differentiation of Th1-type cells triggered by immunization cannot however be 307 
ruled out. Also, very low levels of IL-4 were detected in both immunized and 308 
control mice splenocyte cultures. Infection of IL-12-deficient mice with 309 
Leishmania without increased IL-4 production has been reported in previous 310 
studies [44]. 311 
The protective effect of the used immunization approach observed here 312 
was similar to the one previously obtained in intragastrically infected wild type 313 
mice [18, 19]. Although no direct comparison can be made, since infection route 314 
and inoculum were distinct, Il12b-/- immunized animals generally presented lower 315 
or no detectable brain parasitic burden, as previously observed. Neutralization of 316 
IFN- markedly increased the parasitic burden in immunized mice to values 317 
similar to the ones detected in sham-immunized controls receiving either isotype 318 
control or IFN- neutralizing mAb. This result confirmed the major role of IFN- in 319 
host protection in the i.n. immunized Il12b-/- mice. As CD4+ and CD8+ T cells as 320 
well as NKT cells have been shown to produce IFN- in N. caninum infected hosts 321 
[23, 31], it would be interesting to assess in future studies the particular 322 
contribution of these T cell populations to the protective effect induced by 323 
immunization in the immunodeficient host used here.  324 
 Altogether, the obtained results excluded a major role of IgG antibodies in 325 
protecting from systemic N. caninum infection and emphasized the main role of 326 
IFN- in the protective mechanism elicited by the used i.n. immunization with 327 
NcMP and CpG. Moreover, our results show that the used mucosal immunization 328 
can induce systemic protection against N. caninum that was effective in i.p. 329 
infected mice harboring a mutation that compromises Th1-type immunity. This 330 
indicates that vaccination would be worth exploring as a host protective strategy 331 
against intracellular parasites in hosts with depressed cell-mediated immunity. 332 
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  489 
Fig. 1. Mucosal immunization induces the production of N. caninum-specific IgG 490 
and IFN-. (A) Parasite-specific IgG, IgG1 and IgG2c isotype levels in the serum 491 
of mice immunized twice i.n. with NcMP plus CpG adjuvant (NcMP/CpG) or 492 
sham-immunized with CpG adjuvant alone (CpG), as indicated, 3 weeks after 493 
boost immunization. Data is presented as log10 of the antibody titres. Results 494 
correspond to pooled data of two independent experiments with a total number 495 
of 12-14 mice per group. Each dot represents an individual mouse. Bars 496 
correspond to the mean value in each group. Numbers above bars correspond to 497 
the IgG1/IgG2c ratio. BDL - below detection limit; (B) IFN- and IL-4 concentration 498 
in the supernatants of mesenteric lymph nodes (MLN) or splenocytes cell cultures 499 
unstimulated or stimulated for 3 days with NcS. Cells were isolated from the 500 
spleens and MLN of mice 3 weeks upon the last of two i.n. with NcMP and CpG 501 
(NcMP/CpG) or sham-immunized with CpG (CpG). Results correspond to one 502 
representative experiment out of two independent experiments. Number of 503 
samples per group: CpG n=4; NcMP/CpG n=4. Stimulated cells were plated in 504 
triplicates per mouse per condition. Each dot represents the mean concentration 505 
of triplicate samples per assessed condition with cells from each individual 506 
mouse. Bars correspond to the mean value in each group. (unpaired t-test ** p < 507 
0.01; *** p < 0.001). 508 
 509 
Fig. 2. Protective effect of NcMP/CpG immunization against N. caninum infection 510 
in i.p. challenged Il12b-/- mice. (A) Parasitic load assessed by qPCR three days 511 
(Lungs) or one week (Brain) upon i.p. challenge with 1 × 104 N. caninum 512 
tachyzoites in mice immunized with NcMP and CpG adjuvant (NcMP/CpG) or 513 
sham-immunized with CpG alone (CpG). Data is presented as log10 of the 514 
number of parasites per gram of tissue; n = 8 per group (Lungs, day 3 upon 515 
infection); n = 14 per group (Brain, day 7 upon infection). Each symbol represents 516 
an individual mouse. Bars correspond to the mean value in each group; (unpaired 517 
t-test ***p < 0.001); (B) Parasite-specific IgG, IgG1 and IgG2c isotype levels in 518 
the serum of immunized mice (NcMP/CpG) and controls (CpG), as indicated, 7 519 
days after i.p. infection with 1 × 104 N. caninum tachyzoites. Data is presented as 520 
log10 of the antibody titres. Results correspond to pooled data of two independent 521 
experiments with a total number of 14 mice per group. Each dot represents an 522 
individual mouse. Bars correspond to the mean value in each group. Numbers 523 
above bars correspond to the IgG1/IgG2a ratio. BDL - below detection limit; (C) 524 
IFN- and IL-4 concentration in the supernatants of splenocyte cell cultures 525 
unstimulated (-) or stimulated for 3 days with NcS (+). Cells were isolated from 526 
the spleens of immunized mice (NcMP/CpG) or controls (CpG), 3 and 7 days 527 
after i.p. infection with 1 × 104 N. caninum tachyzoites. Results correspond to 528 
pooled data of two independent experiments with a total number of mice per 529 
group of 8 (3 days) or 14 (7days). Each dot represents an individual mouse. Bars 530 
correspond to the mean value in each group (unpaired t-test *** p < 0.001). 531 
 532 
Fig. 3. Passive immunization confers limited protection against N. caninum i.p. 533 
challenge. Parasitic load assessed by qPCR in mice passively immunized with 534 
IgG-CpG or IgG-NcMP, as indicated, and subsequently challenged i.p. with 1 × 535 
104 N. caninum tachyzoites.  Data is presented as log10 of the number of parasites 536 
per gram of tissue, collected 7 days upon the i.p. challenge. Results correspond 537 
to pooled data of two independent experiments with a total number of 8 mice per 538 
group. Each dot represents an individual mouse. Bars correspond to the mean 539 
value in each group (unpaired t-test ∗∗ p < 0.01).  540 
 541 
Fig. 4. IFN- neutralization abrogates protection conferred by immunization. (A) 542 
Parasitic load assessed by qPCR in the brain of immunized (NcMP/CpG) or 543 
sham-immunized (CpG) mice, 7 days after i.p. challenge with 1 × 104 N. caninum 544 
tachyzoites, treated with IFN--specific mAb (IFN- mAb) or isotype control, as 545 
indicated, 12 h prior to the i.p. infection. Results correspond to pooled data of two 546 
independent experiments with a total number of mice per group of 6 (isotype 547 
control) and of 10 (IFN- mAb). Each dot represents an individual mouse. Bars 548 
correspond to the mean value in each group; (Two-way ANOVA followed by 549 
multiple comparison test; ∗∗ p < 0.01; ∗∗∗∗ p < 0.0001). BDL - below detection 550 
limit. (B) Parasite-specific IgG2c levels in the serum of immunized mice 551 
(NcMP/CpG) and controls (CpG), as indicated, of the same groups as above. 552 
Data is presented as log10 of the antibody titres. Bars correspond to the mean 553 
value in each group. BDL - below detection limit. 554 
 555 
 556 




Supplementary material 1. IL-18-neutralizing mAb did not affect parasite-
antigen stimulated FN- production by splenocytes of immunized Il12b-/- mice.  
 
 
 
 
IFN- concentration in the supernatants of splenocyte cell cultures unstimulated 
(-) or stimulated for 3 days with N. caninum sonicates (NcS) (+) in the absence 
(0) or presence of 1 or 10 g/ml of anti-IL-18 mAb (1 and 10, respectively). Cells 
were isolated from the spleens of Il12b-/- immunized mice (NcMP/CpG) or 
controls (CpG), 7 days after i.p. infection with 1 × 104 N. caninum tachyzoites. 
Bars correspond to the mean value in each group; (One-way ANOVA and 
Tuckey’s multiple comparison test; ∗∗∗∗ p < 0.0001). Neutralization of IL-18 was 
done using anti-mouse IL-18 mAb (1 and 10 g/ml), purified from culture 
supernatants of SK113AE-4 hybridoma (kindly provided by Prof. Irmgard Förster, 
Institut für Umweltmedizinische Forschung, University of Düsseldorf gGmbH) 
using a HiTrap™ protein G HP column (GE Healthcare, Sweden). Anti-IL-18 mAb 
was added concomitantly with NcS. Controls were similarly treated with mouse 
IgG1 isotype control. 
 
 
Supplementary material 2. Parasite-specific IgG1 and IgG2c antibody levels in 
willd-type or IFN--deficient C57BL/6 mice immunized with NcMP plus CpG. 
 
Neospora caninum sonicates-specific IgG1 and IgG2c levels detected by ELISA 
in the serum of wild-type or IFN--deficient (Ifng-/-) C57BL/6 mice immunized twice 
i.n. with N. caninum membrane protein extracts NcMP plus CpG adjuvant 
(NcMP/CpG) or sham-immunized with CpG adjuvant alone (CpG), as indicated, 
3 weeks after boost immunization. Data is presented as log10 of the antibody 
titres. Each dot represents an individual mouse. Bars correspond to the mean 
value in each group. BDL - below detection limit. 
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